The role of tyrosine kinase in hypoxic constriction of sheep pulmonary artery rings

European Journal of Pharmacology

Volumn 358, Issue 1, 1998, Pages 41-47

  Uzun, Özge ^a   Demiryürek, A Tuncay ^a   Kanzik, Ilker ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Genistein; Hypoxia; Sodium orthovanadate; Tyrphostin

Indexed keywords

GENISTEIN; PROTEIN TYROSINE KINASE; SEROTONIN; TYRPHOSTIN; VANADATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPOXIA; HYPOXIC LUNG VASOCONSTRICTION; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SHEEP; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; ANOXIA; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; GENISTEIN; MUSCLE CONTRACTION; PROTEIN-TYROSINE KINASES; PULMONARY ARTERY; SEROTONIN; SHEEP; STRESS, MECHANICAL; TYRPHOSTINS; VANADATES; VASOCONSTRICTION; VASODILATION;

EID: 0032566497     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00592-5     Document Type: Article

References (39)

1. Abebe W., Agrawal D.K. Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle. J. Cardiovasc. Pharmacol. 26:1995;153-159.
2. Akiyama T., Ishida J., Nagakawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:1987;5592-5593.
3. Amatya M.P., Demiryürek A.T., Kane K.A., Wadsworth R.M., Zeitlin I.J. The role of prostacyclin and other mediators in hypoxic constriction of sheep isolated coronary artery rings. J. Vasc. Med. Biol. 1:1989;341-346.
4. Chao W., Liu H., Hanahan D.J., Olson M.S. Protein tyrosine phosphorylation and regulation of the receptor for platelet-activating factor in rat Kupffer cells. Effect of sodium vanadate. Biochem. J. 288:1992;777-784.
5. Demiryürek A.T., Wadsworth R.M., Kane K.A. Effects of hypoxia on isolated intrapulmonary arteries from the sheep. Pulm. Pharmacol. 4:1991;158-164.
6. Demiryürek A.T., Wadsworth R.M., Kane K.A. Pharmacological evidence for the role of mediators in hypoxia-induced vasoconstriction in sheep isolated intrapulmonary artery rings. Eur. J. Pharmacol. 203:1991;1-8.
7. Demiryürek A.T., Wadsworth R.M., Kane K.A., Peacock A.J. The role of endothelium in hypoxic constriction of human pulmonary artery rings. Am. Rev. Respir. Dis. 147:1993;283-290.
8. Demiryürek A.T., MacLean M.R., Wadsworth R.M., Kane K.A. Effects of hypoxia on endothelin-1 release from human, sheep and rabbit pulmonary artery rings. Endothelium. 1:1994;251-258.
9. Di Salvo J., Semenchuk L.A., Lauer J. Vanadate-induced contraction of smooth muscle and enhanced protein tyrosine phosphorylation. Arch. Biochem. Biophys. 304:1993;386-391.
10. Di Salvo J., Steusloff A., Semenchuk L., Satoh S., Kolquist K., Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem. Biophys. Res. Commun. 190:1993;968-974.
11. +2 sensitivity for contraction of smooth muscle. Can. J. Physiol. Pharmacol. 72:1994;1434-1439.
12. Elberg G., Li J., Shechter Y. Vanadium activates or inhibits receptor and non-receptor protein tyrosine kinases in cell-free experiments, depending on its oxidation state. Possible role of endogenous vanadium in controlling cellular protein tyrosine kinase activity. J. Biol. Chem. 269:1994;9521-9527.
13. Gaine S.P., Hales M.A., Flavahan N.A. Hypoxic pulmonary endothelial cells release a diffusible contractile factor distinct from endothelin. Am. J. Physiol. 274:1998;L657-664.
14. Gazit A., Yaish P., Gilon C., Levitzki A. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem. 32:1989;2344-2352.
15. 2+-dependent action potentials in small pulmonary arteries of the cat. J. Appl. Physiol. 59:1985;1389-1393.
16. Hollenberg M.D. Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol. Sci. 15:1994;108-114.
17. +2 dependent manner. Mol. Cell. Biol. 10:1990;6290-6298.
18. 2+-dependent increase in tyrosine kinase activity stimulated by angiotensin II. Proc. Natl. Acad. Sci. USA. 89:1992;8837-8841.
19. Jin N., Packer C.S., English D., Rhoades R.A. Inositol triphosphate is involved in norepinephrine but not in hypoxia induced pulmonary arterial contraction. Am. J. Physiol. 264:1993;L160-L164.
20. Jin N., Siddiqui R.A., English D., Rhoades R.A. Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle. Am. J. Physiol. 271:1996;H1348-H1355.
21. Keatinge N. Sodium flux and electrical activity of arterial smooth muscle. J. Physiol. 194:1968;183-200.
22. Laniyonu A., Saifeddine M., Ahmad S., Hollenberg M.D. Regulation of vascular and gastric smooth muscle contractility by pervanadate. Br. J. Pharmacol. 113:1994;403-410.
23. Laniyonu A.A., Saifeddine M., Yang S.G., Hollenberg M.D. Tyrosine kinase inhibitors and the contractile action of G-protein-linked vascular agonists. Can. J. Physiol. Pharmacol. 72:1994;1075-1085.
24. Levitzki A., Gilon C. Tyrphostins as molecular tools and potential antiproliferative drugs. Trends Pharmacol. Sci. 12:1991;171-173.
25. +2 stores in vascular smooth muscles. Can. J. Physiol. Pharmacol. 74:1996;298-304.
26. Madden J.A., Dawson C.A., Harder D.R. Hypoxia-induced activation in small isolated pulmonary arteries from the cat. J. Appl. Physiol. 59:1985;113-118.
27. McMurtry I.F., Davidson A., Reeves J., Grover R.F. Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs. Circ. Res. 38:1976;99-104.
28. Miller D.S., Hamilton Y.A., Paterson N.A.M. Role of aracidonic acid metabolites in hypoxic contraction of isolated porcine pulmonary artery vein. Exp. Lung Res. 15:1989;213-222.
29. Post J., Hume J., Archer S., Weir E.K. Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am. J. Physiol. 262:1992;C882-C890.
30. Raeymeakers L., Wuytack F., Eggermont J., De Schutter G., Casteels R. Isolation of plasma membrane fraction from gastric smooth muscle. Biochem. J. 210:1983;315-322.
31. Rodman D.M., Yamaguchi T., O'Brien R., McMurty I. Hypoxic vasoconstriction of isolated rat pulmonary artery. J. Pharmacol. Exp. Ther. 248:1989;952-959.
32. Rorie D.K., Tyce G.M. Effects of hypoxia on norepinephrine release and metabolism in dog pulmonary artery. J. Appl. Physiol. 55:1983;750-758.
33. Sanchez-Ferrer C., Marin J., Lluch M., Valverde A., Salaices M. Action of vanadate on vascular tension and sodium pump activity in cat isolated cerebral and femoral arteries. Br. J. Pharmacol. 93:1988;53-60.
34. Swarup G., Cohen S., Garbers D.L. Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem. Biophys. Res. Commun. 107:1982;1104-1109.
35. Tsuda T., Kawahara Y., Shii K., Koide M., Ishida Y., Yokoyama M. Vasoconstrictor-induced protein-tyrosine phosphorylation in cultured vascular smooth muscle cells. FEBS Lett. 285:1991;44-48.
36. Voelkel N.F., Czartolomna J. Vanadate potentiates hypoxic pulmonary vasoconstriction. J. Pharmacol. Exp. Ther. 259:1991;666-672.
37. Wadsworth R.M. Vasoconstrictor and vasodilator effects of hypoxia. Trends Pharmacol. Sci. 15:1994;47-53.
38. Watts S.W., Yeum C.H., Camphell G., Webb R.C. Serotonin stimulates protein tyrosyl phosphorylation and vascular contraction via tyrosine kinase. J. Vasc. Res. 33:1996;288-298.
39. Zhao Y., Packer S., Rhoades R.A. Hypoxia-induced pulmonary arterial contraction appears to be dependent on myosin light chain phosphorylation. Am. J. Physiol. 15:1996;L768-L774.